TTE Improves Clinical Management of Stable Chest Pain
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: TTE.
- Who it may be relevant to
- Registry conditions: Transthorcic Echocardiography, Stable Angina Pectoris, Coronary Artery Disease, Major Adverse Cardiac Events. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Improving the Clinical Management of Stable Chest Pain Based on Imaging: a Registry of Transthorcic Echocardiography
Overview
The investigator aims to prospectively enroll patients who were referred for transthorcic echocardiography (TTE) for the assessment of stable chest pain (SCP) suspected of obstructive coronary artery disease (CAD). All patients underwent TTE according to established guidelines and local institutional protocols. This study will determine if TTE-based imaging evaluation can provide more informaton to improve clinical management for SCP, including fewer MACE and better decision-making of downstream investigations and therapeutic interventions.
Interventions
- Diagnostic test TTE
All patients underwent TTE according to established guidelines and local institutional protocols. The imaging data were evaluated using different image post-processing software to comprehensively analyse anatomical, functional and histological information of coronary.
Primary outcome measures
- Major adverse cardiovascular events [Time frame: 10 years]
Secondary outcome measures (3)
- Invasive coronary angiography [Time frame: 10 years]
- Medication prescription [Time frame: 10 years]
- Coronary revascularization [Time frame: 10 years]
Eligibility criteria
Inclusion criteria
- symptomatic patients with SCP suspected of obstructive CAD.
- referred for TTE for the assessment of SCP.
- ≥18 years of age.
- signed informed consent.
Exclusion criteria
- acute coronary syndromes
- previous CAD or coronary revascularization
- nonsinus rhythm
- cardiomyopathy, valvular disease, congenital heart disease or left cardiac insufficiency because of other reasons
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Tianjin Chest Hospital — Tianjin
Identifiers
NCT: NCT07063147 · 2025KY-019-01